Share

Biosimilars

Download Biosimilars PDF Online Free

Author :
Release : 2018-12-13
Genre : Medical
Kind : eBook
Book Rating : 800/5 ( reviews)

GET EBOOK


Book Synopsis Biosimilars by : Hiten J. Gutka

Download or read book Biosimilars written by Hiten J. Gutka. This book was released on 2018-12-13. Available in PDF, EPUB and Kindle. Book excerpt: This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a development path of a new drug, tailored by the mechanism of action, the quality of the molecule, published information on the reference product, the current competitive environment, the target market and regulatory guidance, and most importantly, the emerging totality of evidence for the proposed biosimilar during development. For the ease of readers, the book comprises of six sections as follows: Section I: Business, Health Economics and Intellectual Property Landscape for Biosimilars Section II: Regulatory Aspects of Development and Approval for Biosimilars Section III: Biopharmaceutical Development and Manufacturing of Biosimilars Section IV: Analytical Similarity Considerations for Biosimilars Section V: Clinical aspects of Biosimilar Development Section VI: Biosimilars- Global Development and Clinical Experience Chapters have been written by one or more experts from academia, industry or regulatory agencies who have been involved with one or more aspects of biosimilar product development. The authors and editors have an expertise in commercialization and pricing of biosimilars, intellectual property considerations for biosimilars, chemistry manufacturing controls (CMC) and analytical development for biosimilars, regulatory and clinical aspects of biosimilar development. Besides the industry practitioners, the book includes several contributions from regulators across the globe.

Biologics, Biosimilars, and Biobetters

Download Biologics, Biosimilars, and Biobetters PDF Online Free

Author :
Release : 2021-02-03
Genre : Medical
Kind : eBook
Book Rating : 654/5 ( reviews)

GET EBOOK


Book Synopsis Biologics, Biosimilars, and Biobetters by : Iqbal Ramzan

Download or read book Biologics, Biosimilars, and Biobetters written by Iqbal Ramzan. This book was released on 2021-02-03. Available in PDF, EPUB and Kindle. Book excerpt: A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective. Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics

Download Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics PDF Online Free

Author :
Release : 2015
Genre :
Kind : eBook
Book Rating : /5 ( reviews)

GET EBOOK


Book Synopsis Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics by : Lisa M.. Plitnick

Download or read book Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics written by Lisa M.. Plitnick. This book was released on 2015. Available in PDF, EPUB and Kindle. Book excerpt:

Biosimilars of Monoclonal Antibodies

Download Biosimilars of Monoclonal Antibodies PDF Online Free

Author :
Release : 2016-12-09
Genre : Medical
Kind : eBook
Book Rating : 628/5 ( reviews)

GET EBOOK


Book Synopsis Biosimilars of Monoclonal Antibodies by : Cheng Liu

Download or read book Biosimilars of Monoclonal Antibodies written by Cheng Liu. This book was released on 2016-12-09. Available in PDF, EPUB and Kindle. Book excerpt: Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing. • Guides readers through the complex landscape involved with developing biosimilar versions of monoclonal antibody (mAb) drugs • Features flow charts, tables, and figures that clearly illustrate processes and makes the book comprehensible and accessible • Includes a review of FDA-approved mAb drugs as a quick reference to facts and useful information • Examines new technologies and strategies for improving biosimilar mAbs

Fast Facts: Biosimilars in Hematology and Oncology

Download Fast Facts: Biosimilars in Hematology and Oncology PDF Online Free

Author :
Release : 2020-01-23
Genre : Medical
Kind : eBook
Book Rating : 219/5 ( reviews)

GET EBOOK


Book Synopsis Fast Facts: Biosimilars in Hematology and Oncology by : Paul Cornes

Download or read book Fast Facts: Biosimilars in Hematology and Oncology written by Paul Cornes. This book was released on 2020-01-23. Available in PDF, EPUB and Kindle. Book excerpt: Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars – particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Fast Facts: Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients. Contents: • Biologics and the need for biosimilars • Why do we need biosimilars? • How is the quality of biosimilar medicines assured? • Legal issues • Switching, interchangeability and extrapolation • Safety and pharmacovigilant • Global issues • Formulary considerations: pharmacy issues • Formulary considerations: supportive care biosimilars • Formulary considerations: therapeutic anti-cancer biosimilars • Communication and awareness

You may also like...